General

Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
New advanced therapies facility offers promise for hard-to-treat diseasesNew advanced therapies facility offers promise for hard-to-treat diseasesPress release: FourPlus and Cell and Gene Therapy Catapult deliver cutting-edge VR training technologyPress release: FourPlus and Cell and Gene Therapy Catapult deliver cutting-edge VR training technologyRinri Therapeutics secures Innovate UK funding grant for £3.2m project to advance its novel cell-based therapy to restore hearing lossRinri Therapeutics secures Innovate UK funding grant for £3.2m project to advance its novel cell-based therapy to restore hearing lossRoslinCT has been selected as the second National Training Centre in the Advanced Therapies Skills Training NetworkRoslinCT has been selected as the second National Training Centre in the Advanced Therapies Skills Training NetworkATTC network establishes first Advanced Therapies NHS Readiness ToolkitATTC network establishes first Advanced Therapies NHS Readiness ToolkitNational Horizons Centre expands as National Training Centre for the Advanced Therapies Skills Training Network (ATSTN)National Horizons Centre expands as National Training Centre for the Advanced Therapies Skills Training Network (ATSTN)Press release: GSK expands its clinical trial manufacturing capacity for cell and gene therapy at the Cell and Gene Therapy Catapult facility in StevenagePress release: GSK expands its clinical trial manufacturing capacity for cell and gene therapy at the Cell and Gene Therapy Catapult facility in StevenagePress release: 2020 clinical trials database report confirms the UK as an internationally attractive clinical space for the development of cell and gene therapiesPress release: 2020 clinical trials database report confirms the UK as an internationally attractive clinical space for the development of cell and gene therapiesPress release: Rentschler Biopharma to build new cell and gene therapy capabilities in the UKPress release: Rentschler Biopharma to build new cell and gene therapy capabilities in the UKCGT Catapult’s third annual clinical adoption workshop offers recommendations for advancing institutional readiness across the NHS to accelerate the routine adoption of cell and gene therapiesCGT Catapult’s third annual clinical adoption workshop offers recommendations for advancing institutional readiness across the NHS to accelerate the routine adoption of cell and gene therapiesPress release: Hertfordshire LEP to part-fund state-of-the-art cell and gene therapy training centre to strengthen the sector’s skills pipelinePress release: Hertfordshire LEP to part-fund state-of-the-art cell and gene therapy training centre to strengthen the sector’s skills pipelineFormer CGT Catapult Chief Executive Offer awarded CBE for Services to Science and InnovationFormer CGT Catapult Chief Executive Offer awarded CBE for Services to Science and Innovation